SIRT2 and obesity disorder: We and others have shown that SIRT2 deacetylates and deactivates NFκB p65 and prolongs the immunosuppressive hypo-inflammatory phase of sepsis with obesity, a common co-morbidity in sepsis patients (22, 27, 28).